Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, July 22 at 2:00 PM EDT

Register Free →

This Solicitation opportunity from Government of Canada was posted on November 11, 2022. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Subscription to the Pharma Intelligence Center – Drugs Database & Trials Intelligence

Closed
SN22005Canada

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Government of Canada → Patented Medicine Prices Review BoardView Agency

NAICS

N/A

Place of Performance

*National Capital Region (NCR), CAN

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyGovernment of Canada → Patented Medicine Prices Review Board
Contacts1 person available
OfficeN/A
Organization / Agency
Government of Canada → Patented Medicine Prices Review Board
View Agency Profile
Office AddressN/A
Contacts
Laneve NadiaPoint of Contact

Full Description

Show more
The PMPRB gathers intelligence and data on international pricing and reimbursement regimes/policies and trends to carry out its price review process, develop strategic advice and report on national and international trends. To perform these functions, the PMPRB needs to invest considerable resources both internally and externally to gathering and analyzing the best available information on global pricing and reimbursement of pharmaceuticals.